Alteration of branch site consensus sequence and enhanced pre-mRNA splicing of an NMDAR1 intron not associated with schizophrenia

Am J Med Genet. 2002 Aug 8;114(6):631-6. doi: 10.1002/ajmg.10646.

Abstract

Aberrant splicing of pre-mRNA is recognized to account for a significant minority of disease-causing mutations. The N-methyl-D-aspartate receptor (NMDA) subunit gene R1 (NMDAR1) is alternatively spliced to produce eight length variants. In an examination of the NMDAR1 as a candidate gene in schizophrenia, a presumed microdeletion/insertion (del/ins) was observed in intron 10 of an African-American male near a weak putative branch-site consensus sequence. Although exon 10 is not known to be alternatively spliced, the del/ins was posited to alter splicing efficiency. If splicing were abolished and intron retention occurred, an in-frame translation product of more than 250 amino acids was predicted. To explore splicing efficiency, mini genes were examined through primer-extension analyses in NIH293 embryonic kidney cell cultures. Rather than disruption of splicing, the del/ins allele exhibited a fivefold enhancement in splicing. In an association analysis with additional schizophrenic cases and unaffected controls, all of African-American descent, the mutant allele was observed at equivalent frequencies. A family study also did not support cosegregation of the variant allele with psychiatric disease.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Alternative Splicing / genetics*
  • Case-Control Studies
  • Consensus Sequence
  • DNA Primers
  • Female
  • Genetic Variation
  • Humans
  • Introns*
  • Male
  • Plasmids
  • Polymerase Chain Reaction
  • RNA Precursors / genetics*
  • RNA, Messenger / metabolism*
  • Receptors, N-Methyl-D-Aspartate / genetics*
  • Schizophrenia / diagnosis
  • Schizophrenia / genetics*
  • Sequence Deletion
  • Transfection

Substances

  • DNA Primers
  • NMDA receptor A1
  • RNA Precursors
  • RNA, Messenger
  • Receptors, N-Methyl-D-Aspartate